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Background: Methicillin-resistant Staphylococcus aureus (MRSA) is an important nosoco- 
mial pathogen i  acute care hospitals and long-term care facilities. Few studies have been 
reported in private skilled nursing facilities (SNFs) not experiencing outbreaks of infections 
caused by MRSA. 
Methods: From a 149-bed SNF with no outbreaks, we report a 1-year prospective surveil- 
lance study of S. aureus colonization and infection, with focus on S. aureus phenotypes, 
both methicillin susceptible (MS) and methicillin resistant (MR). Nasal and stool or rectal 
screening cultures were done on admission, and all patients underwent screening on at 
least a quarterly basis for 1 year. 
Results: Overall, 35% of patients were colonized at least once with S. aureus, (72% MS, 
25% MR, and 3% mixed phenotypes), 94% of the MRSA were ciprofloxacin resistant. Nasal 
colonization with any S. aureus was more frequent, but 13% of patients had positive results 
only in rectal specimens. Twenty-one percent of the newly admitted and 15% of continuing 
patients acquired colonization during their stay in the SNE Colonization was transient or 
persistent, persisted longer in the nares compared with colonization i rectal specimens, 
and was more stable for methicillin-susceptible S. aureus. Nine percent of patients had 
development of infection with S. aureus. There was no indication that MRSA colonization 
led to more infections than methicillin-susceptible S. aureus. Of the 13 infected patients in 
whom cultures had previously been obtained, seven (54%) had been colonized by the same 
phenotype strains. 
Conclusions: In this private SNF, endemic S. aureus infections occur at a low frequency, re- 
flecting a moderate l vel of colonization with S. aureus. However, a trend showing radual 
increases in frequencies ofcolonization and infection is of concern and suggests hat in this 
SNF, future intervention could become warranted. (AJIC Am J Infect Control 1997;25:312-21) 
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Since 1970 meth ic i l l i n - res i s tant  Staphy lococcus  
aureus  (MRSA) has become an  impor tant  noso~ 
comia l  pathogen in  acute  care hosp i ta ls  (ACH). In  
recent  years  reports  f rom long- term care faci l i t ies 
(LTCF) of co lon izat ion  and  in fec t ion  w i th  these 
organ isms have increased;  most  of these have 
been conducted  in  Veterans  Affairs (VA)-aff i l iated 
LTCF. 1 Few studies2-4 have been conducted  in  pri -  
vate ski l led nurs ing  faci l i t ies (SNFs),  wh ich  repre-  
sent  the large major i ty  of the LTCF in  this  country.  
Whether  ACH are the source  of MRSA in  LTCF is 
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not clear. Some suggest hat MRSA strains are in- 
troduced into LTCF by patients who have become 
colonized or infected in the ACH before transfer to 
the LTCF? Conversely, other studies uggested that 
patients entering an ACH colonized with MRSA 
were transferred from LTCF. 6,7 Occasional epi- 
sodes of transmission from colonized medical per- 
sonnel have been reported? Studies from VA hos- 
pitals have shown that 5% to 15% of colonized 
patients will have development of MRSA infec- 
t ions/  which are often difficult to treat when they 
occur. This is especially true of MRSA that are also 
resistant to ciprofloxacin (CR). However, little data 
are available regarding the endemic frequency of 
MRSA colonization in community SNF settings. 
Whether the incidence of colonization with MRSA 
has increased over time in SNFs is also not clear. 
To derive potential strategies for control, addi- 
tional data are needed to determine whether colo- 
nization and infection frequencies are indeed 
changing in the setting of the SNF. 
The anatomic sites of colonization may also be 
important. However, evaluation of nares versus 
rectal swabs for detection and for monitoring col- 
onization longitudinally has not been reported in 
a community SNE Furthermore, significant ques- 
tions remain with regard to the relationship of 
colonization to subsequent infection and the path- 
ogenicity of methicillin- resistant strains of S. 
aureus  . 
In a community SNF we conducted a 1-year 
prospective surveillance study of S.  aureus  colo- 
nization and infection, with focus specifically on 
strain phenotypes both sensitive and resistant o 
methicillin and ciprofloxacin. We evaluated the 
frequencies of colonization over time by anatom- 
ic sites, the referral sources of admission, colo- 
nization status on admission, and patient debility 
levels. We also examined the persistence of colo- 
nization and the relation between colonization 
and infection. 
METHODS 
Study facility and population 
A private 149-bed SNF in Orange County, 
California, was selected for study. The facility has 
three floors; the first floor (30 beds) houses pri- 
mary care patients with Alzheimer's disease, 
whereas the second (60 beds) and third floors (59 
beds) are reserved for patients with other diag- 
noses. The patients on the second floor are more 
debilitated than those on the first or third floors. 
Nursing staff rotate in all three floors. The occu- 
pancy rate during the study period was 95% to 
100%; the average length of stay was 117 days. 
Surveil lance of infections 
The overall study design was observational sur- 
veillance. Routine infection control surveillance 
was conducted by regular SNF personnel follow- 
ing published guidelinesY Study personnel pro- 
spectively received from the SNF infection control 
nursing supervisor the infection surveillance data 
developed by the SNF personnel, including nurs- 
ing logs, medical charts, microbiologic studies, 
and other laboratory reports. Records of antibiotic 
treatment were obtained from the pharmacy and 
nursing logs. Most prescriptions were 7 to 14 days; 
therefore for purposes of analyses presented in 
this report, we have presented the antibiotic uti- 
lization frequencies imply by numbers of pre- 
scriptions, without analysis for total grams or total 
days. For purposes of this study, a presumptive in- 
fection episode was recorded when symptoms and 
signs were considered by the SNF nursing staff 
and the patient's private physician to represent in- 
fection, and antibiotic treatment was initiated. 
Clinical diagnoses were supplemented by labora- 
tory tests ordered by the patient's private physi- 
cian, such as blood counts, chest radiograms, uri- 
nalyses, and bacterial cultures. Study personnel 
did not examine patients or influence diagnostic or 
treatment modalities. Routine cultures for diagno- 
sis of suspected infections were performed by a 
single commercial laboratory. Review of the epi- 
demiologic pattern of infection episodes revealed 
no seasonal trends or apparent focal clusters 
within the SNF; instead, the infections eemed to 
represent a low-level, endemic incidence. 
Colonization surveil lance of patients with 
S.  aureus  
Screening surveillance cultures for colonization 
of patients' microbial flora with S.  aureus  were 
done every 3 months on all patients. Newly admit- 
ted or readmitted patients were screened on 
admission (or within 72 hours). The sources of 
screening cultures included swabs taken from 
anterior nares (both sides with one swab) and 
swabs from stool or rectal area. Few patients had 
wounds or indwelling vascular lines; therefore 
wounds or vascular catheters were not included in 
the study cultures. 
Colonization definitions 
For overall study analyses, colonization was de- 
fined in a patient with any surveillance culture re- 
AJIC 
314 Lee et al. August 1997 
Table 1, Colonization and infection frequencies by S. aureus  MR and MS phenotypes, and quinolone prescriptions, by 
year of surveillance 
Phenotype 1989 1990-1992 1993-1994 pValue 
Colonization frequencies-% of patients 
MRSA ND 7.9* 9.71- NS 
MRCR.SA ND 5.4* 9.01- S 
MS.SA ND ND 25 
Multi-strains ND ND 1.0 
All SA ND ND 35 
MRSA/SA (%) ND ND 28 
MRCR/MRSA (%) ND 68 93 NS 
Infection frequencies-% of patients 
MR.SA ND 1.6 3.9 S 
MRCR.SA ND 1.4 3.6 S 
MS.SA ND 2.6 4.1 NS 
Multi-strains ND 0.2 0.8 
Not known ND - - 
All SA 4.6 4.2 8.8 S 
MRSA/SA (%) ND 38 53 NS 
MRCR/MRSA (%) ND 88 92 NS 
Quinolone~ 
Prescriptions (% of all prescriptions) 18 21 17 NS 
SA, S. aureus. 
*Data from screening cultures by oxaciilin salt media, the rest were screened by mannitol salt media. 
1-Data limited to surveillance set No. 5, oxacillin salt media. 
:l:Ciprofloxacin plus norfloxacin. 
sult positive for S. aureus at least once, from nares 
or stool. From colonized patients repeat cultures 
were obtained every 3 to 4 weeks to assess persis- 
tence. For patients who were in the SNF long 
enough to undergo two or more surveillance cul- 
tures, colonization definitions were as follows 
(modified from Bradley et al.6): (1) Persistent colo- 
nization was defined as patients with three or more 
consecutive positive culture results with the same 
phenotype (periods of 3 to 4 months or more). (2) 
Partial persistent was defined as patients with 2 
consecutive culture results positive for the same 
phenotype, but additional follow-up cultures were 
not done (e.g., patient discharged), or one or more 
episodes with two consecutive positive culture re- 
sults, followed by or interspersed with one or more 
negative culture results. (3) Intermittent was de- 
fined as positive culture results on two or more oc- 
casions, but no two consecutive positive results of 
the same phenotype. (4) Transient colonization was 
defined as only one positive culture result during 
the entire study period. 
Microbiology methods 
Screening culture swabs from anterior nares 
and stool were placed in standard commercial cul- 
turettes with holding media and held at 4 ° C until 
they were plated, within 1 to 4 hours. In our previ- 
ous study of this SNF (1990-1992), oxacillin salt 
media was used to screen only for MRSA, which 
did not provide a denominator f total patients col- 
onized with any S. aureus. Therefore in this study 
the swabs were plated on mannitol salt agar media 
to screen for all S. aureus. In addition, to compare 
the results with results from 1990 to 1992 (22 
months), for one of the surveillance sets (set no. 5), 
all specimens were plated on oxacillin salt agar in 
addition to mannitol salt agar media. The recovery 
rate of MRSA from mannitol salt (9.0% of patients) 
was not significantly different from that of 
oxacillin salt (9.7%). The oxacillin salt results are 
summarized in Table 1. 
Suspected isolates of S. aureus were confirmed 
by the catalase test and the tube coagulase test. 
The antimicrobial susceptibilities of all isolates of 
S. aureus were confirmed by standardized disc-dif- 
fusion procedures in Mueller-Hinton agar plates, 
and zone diameters were measured after 20 to 24 
hours incubation at 35 ° C, according to National 
Committee for Clinical Laboratory Standards 
guidelines, n° Isolates were confirmed as methi- 
cillin resistant (MR) and CR when 1 txg oxacillin 
and 5 Ixg ciprofloxacin disc produced zones of less 
than 10 mm and less than 15 ram, respectively. All 
S. aureus from colonization surveillance cultures 
were saved and harvested from a fresh subculture 
on trypticase soy agar plates with 5% sheep blood 
for storage in fetal bovine serum at -70  ° C. 
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Table 2. Colonization of patients by S. aureus:  distribution of strains by MR and MS phenotypes (1993 to 1994) 
Colonizing SA phenotypes (no. of pattents)t 
No. of cultures 
Survey No. obtained MRSA MSSA Multiple strains~: Total (%) 
Continuing patients 
1. 110 9 21 1 31 (28) 
2 117 10 22 1 33 (28) 
3. 109 7 32 0 39 (36) 
4. 111 9 36 2 47 (42) 
5. 134 16 35 1 52 (39) 
Totals 581 (100) 51 (9) 146 (25) 5 (1) 202 (35) 
(%) Total SA (25) (72) (3) (100) 
Newly admitted patients 182 (100) 12 (7) 33 (18) 2 (1) 47 (26) 
(%) Total SA (26) (70) (4) (100) 
SA, S. aureus. 
*Many patients were surveyed more than once; a totat of 189 patients were included in the five surveys. 
tA patient with one or more positive culture(s) in either one or both nares and stool is considered as colonized. 
:I:Two or more phenotypes were detected. 
Data analysis 
Colonization frequencies were calculated either 
as the number of colonizations per 100 specimens 
or per 100 patients screened. Discrete data were 
compared by chi-square and Fisher's exact tests 
when appropriate. A p value of less than 0.05 was 
considered significant. Data analyses were per- 
formed by EPI Info Software (Centers for Disease 
Control and Prevention, Atlanta, Ga.). 
RESULTS 
Patient population surveyed 
During the 1-year study period five surveillance 
culture sets were obtained from all patients at 3- 
month intervals. A total of 189 continuing patients 
(vs new patients) were surveyed, many more than 
once, and a total of 182 newly admitted patients 
were also surveyed on admission or within 3 days 
after admission. Altogether 354 patients were sur- 
veyed. The mean age of the patients was 79 years, 
and 72% were women. Eighty percent of the resi- 
dents were admitted by transfer from an ACH. 
Distribution of colonization with S.  aureus  by 
MR phenotypes 
For the continuing patients, as shown in Table 
2, the majority (72%) of the total colonizing S. 
aureus  were susceptible to methicillin (MS pheno- 
type), whereas 25% were resistant (MR pheno- 
type), and only a few patients carried multiple 
strains (3%). Table 2 also presents the distribution 
of MR and MS phenotypes for newly admitted 
patients in comparison with the continuing 
patients; the overall patterns were quite similar. 
The frequencies of colonization with S. aureus  
for continuing patients increased gradually with 
each subsequent survey except he final one. The 
frequencies for colonization with any S. aureus  
strain in the first two surveys were significantly 
lower than in the last two (Table 2; 28% vs 41%, 
p < 0.05). Colonization frequencies of MR strains 
also were higher than 2 years previously (9.7% vs 
7.9%), although the increments did not reach sta- 
tistical significance (Table 1). Ninety-four percent 
of the MRSA isolates were CR, which also repre- 
sents an increasing trend compared with 2 years 
previously (88%). Nevertheless colonization of 
patients with S. aureus  tended to increase over 
time, and the mean frequency for the continuing 
patients was significantly higher than that for the 
newly admitted patients (35% vs 26%, p < 0.05) 
(Table 2). 
Distribution of colonization by sampling sites 
As shown in Table 3, of the 204 patients who 
had both nares and stool/rectal swab specimens 
surveyed (during the quarterly culture screening 
and the follow-up cultures), 142 culture pairs 
(70%) had S. aureus  colonization in nares only, 27 
(13%) in stool only (70% vs 13%, p < 0.05), and 35 
(17%) in both sites. Thus total recovery of all S. 
aureus  strains was more frequent from nasal spec- 
imens (87%) than the stool specimens (30%). The 
colonization patterns of S. aureus  in newly admit- 
ted patients' nares and stools were the same pat- 
tern as for the continuing patients. The distribu- 
tion of various antimicrobial resistance pheno- 
types in nares and stools also followed a similar 
pattern. 
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Table 3. Colonization of patients by S. aureus; distribution of MR and MS phenotypes strains by sampling site 
Phenotypes (no. of patients) 
Site of positive 
Patient group culture result MRSA MSSA Multi-strains Total (%) 
Continuing patients Nares only 26 112 4 142 (70) 
Stool only 7 20 0 27 (13) 
Both 1.__6 1_.88 _1 35 (17) 
Total 49 (27%) 150 (74%) 5 (2%) 204 (100%) 
Newly admitted patients Nares only 7 21 1 29 (67) 
Stool only 3 2 1 6 (14) 
Both 1.__3 5 0 ___88 (19) 
Total 13 (30%) 28 (65%) 2 (5%) 43 (100%) 
Table 4. Colonization with MR and MS phenotypes of S. aureus in newly admitted patients, by patient referral source 
Total Not Grand 
Phenotypes of colonized patients colonized colonized total 
(no. of patients) All SA patients patients 
Referral source MRSA MSSA Multi-strains No. (%) No. (%) No. (%) 
ACH 9 25 1 35 75 106 78 141 77 
LTCF 1 5 1 7 15 5 4 12 6 
Community 0 2 0 2 6 9 7 11 7 
Others 1 1 0 2 4 3 2 5 3 
Unidentified 1 0 0 1 2 12 9 13 7 
Total 12 33 2 47 100 135 100 182 100 
SA, S. aureus. 
Colonization by referral source of patients 
admission 
As shown in Table 4, of the 182 patients newly 
admitted uring the study period, 141 (77%) were 
referred directly from an ACH. Of the 47 colo- 
nized patients, 35 (75%) were newly admitted 
from ACH. On the other hand, of the 135 noncol- 
onized patients, from whom S. aureus  was never 
isolated, 106 (78%) were newly admitted from 
ACH. Thus similar proportions of colonized and 
noncolonized patients were admitted from an 
ACH (75% vs 78%, p > 0.05). However, a signifi- 
cantly greater proportion of colonized patients 
came from other LTCF than did the noncolonized 
patients (15% vs 4%, p < 0.05). Furthermore, pa- 
tients admitted from LTCFs had significantly 
higher S. aureus  colonization frequency than pa- 
tients admitted from ACHs (58% vs 25%, p < 0.05) 
(Table 4), although the sample size of admissions 
from LTCF was small. 
Distribution of colonization by patient mobility 
levels 
As shown in Table 5, of the 301 patients with mo- 
bility level data available, 72 (24%) were ambula- 
tory. Eighteen of these 72 ambulatory patients 
were colonized with S. aureus  (25%). On the other 
hand, among the nonambulatory patients (bed, 
bed/chair, or variable status), 116 of 229 (51%) 
were colonized, a significantly higher proportion 
than in ambulatory patients (p < 0.05). Most of the 
nonambulatory patients were housed on the sec- 
ond-floor, where 55% of patients were colonized, 
compared with lower colonization frequencies on 
the first floor (15%) and the third floor (30%). 
Acquisition of S. aureus  colonization 
Of the 182 newly admitted patients, 47 (26%) 
were colonized with S. aureus  (25% MR) on 
admission, and 28 (21%) of the noncolonized 
patients acquired colonization after being admit- 
ted to the facility. Sixteen (57%) of these 28 
patients acquired colonization in the first follow- 
up culture. For newly admitted patients who 
were not colonized on admission, the length of 
stay until colonization was detected ranged 
from 8 days to 175 days, with a mean of 47 days. 
Fifteen percent of continuing patients also 
acquired colonization during their stay in the 
nursing facility. 
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Table 5. Colonization of all patients by S. aureus; distribution of MR and MS phenotypes trains by patient 
Total Not Grand 
Phenotypes of colonized patients colonized colonized total 
(no, of patients) all SA patients patients 
Referral source MRSA MSSA Multi-strains No. (%) No. (%) No. (%) 
Ambul~ory 3 15 0 18 25 54 75 72 24 
Chair/bed 4 31 7 42 51 40 49 82 27 
Bed 4 13 5 22 52 20 48 42 14 
Variable st~us 7 29 13 49 47 56 53 105 35 
Total 18 88 25 131 44 170 56 301 100 
SA, S. aureus. 
*Two or more phenotypes were detected during the study period (different phenotypes at different follow-up cultures). 
Table 6. Persistence of colonization with S. aureus by MR and MS phenotypes 
Total patients Follow-up 
S. aureus initially culture not Persistance 
phenotype colonized* obtained categoryt 
Follow-up cultures obtained 
No. of patients 
2:1: -->3 Subtotal (%) 
MR 38 15 
MS 121 33 
Multi-strains 3 1 
Total 162 49 
23 (100) 
Persistent - 0 6 6 (26) 
Partial persistence 5 0 1 6 (26) 
Intermittent 0 0 1 1 (4) 
Transient 4 3 3 10 (44) 
88 (100) 
Persistent 2 22 24 (27) 
Partial persistence 13 3 10 26 (30) 
Intermittent 1 3 9 13 (15) 
Transient 12 5 8 25 (28) 
2 (100) 
Partial persistence 0 0 1 1 (50) 
Transient 1 ~ _O0 1 (58) 
36 16 61 113 
*A patient with one or more positive culture results in either one or both nares and stool is considered 
1-See text for definitions. 
STime elapsed for the three culture sets (initial screen positive, plus two follow-up cultures) was 3 to 4 
as colonized, 
months, 
Persistence of colonization and change in 
antibiotic resistance phenotype 
The study design called for colonized patients to 
undergo repeat cultures 3 to 4 weeks after the ini- 
tial colonization (in addition to the quarterly sur- 
veillance of all patients). As shown in Table 6, of 
the 162 colonized patients, 49 (30%) did not 
undergo follow-up cultures, mostly because of 
early discharge. Of patients colonized with MR 
phenotypes and with follow-up cultures, 56% 
showed persistence or partial persistence or inter- 
mittent colonization (see definitions in Methods), 
compared with 72% for patients colonized with 
MS phenotype. On average, S. aureus  colonization 
tended to persist longer in the nares compared 
with rectal/stool specimens. Of patients who 
underwent four or more follow-up culture sets 
after the initial detection of colonization, 64% of 
the nares continued to have positive results in 
four or more cultures; however, in the stool/rectal 
specimens, only 32% had four or more positive 
culture results (p < 0.05). In the nares, the mean 
duration range was >234 _+ 78 days (range 11 to 
326+ days); in the stool or rectal specimens, the 
mean duration was >180 _+ 67 days (range 8 to 
291+ days). 
The stability of S. aureus  strains by various 
antimicrobial resistance phenotypes i  shown in 
Table 7. Because of concern regarding acquisition 
of ciprofloxacin resistance in MRSA strains, we 
have examined the stability of CR and MR pheno- 
types (Table 7). Of the 52 patients persistently 
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Table 7, Changes in resistance phenotype pattern during follow-up period 
Initial colonization: phenotypes (no. of patients) 
Follow-up 
phenotypes MRCR MRCS MSCR MSCS Multi-strains Total 
MRCR 6 (50%) 0 1 1 0 12 
MRCS 0 0 (0%) 0 1 0 1 
MSCR 4 0 11 (92%) 3 0 14 
MSCS 2 1 0 47 (90%) 0 53 
Multi-strains 0 0 0 0 1 1 
Total 12 (100%) 1 (100%) 12 (100%) 52 (100%) 1 (100%) 81 
colonized with susceptible strains (MSCS phe- 
notype), the same phenotypes were persistent in 
the follow-up culture in 47 patients (90%); all 11 
of 12 (92%) patients with methicillin-sensitive, 
ciprofloxacin-resistant phenotypes also retained 
the same phenotypes. In contrast, colonization 
with MRCR phenotype was the least stable in the 
follow-up cultures; of the 12 patients who contin- 
ued to have positive results, only six (50%) had the 
same MRCR phenotype. Overall, MS S. aureus  
phenotype colonization appeared more stable 
than MRSA phenotypes. 
Clearance of colonizat ion 
For the 162 patients colonized on at least one oc- 
casion, 57 (35%) had at least one negative culture 
result before the end of the study period. Thirty 
percent of these patients had been treated with an 
antibiotic after colonization and before the nega- 
tive culture results. 
Colonizat ion and subsequent deve lopment  of 
infection 
As shown in Table 8, of 354 patients surveyed, 
32 (9%) had development of infections with S. 
aureus  during the 1-year study. Of these infec- 
tions, 10 (31%) were wound and soft tissue infec- 
tions, followed by respiratory infections (n -- 8) 
and urinary tract infections (n = 7). The frequen- 
cy of infections caused by S. aureus  was higher 
than 2 years previously (9% vs 4%), although the 
use of quinolone antibiotics decreased slightly 
(Table 1). 
During this 1-year study MR and MS strains 
each accounted for 14 and 15 cases of the total S. 
aureus  infections, respectively. There was no indi- 
cation that MRSA caused more infections than 
methicillin-susceptible S. aureus  (MSSA) (44% for 
MR; 47% for MS). Many of the patients who had 
development of infections as a result of S. aureus  
had previously had persistent colonization. Of the 
13 infected patients who had been previously 
included in a culture survey and found to be colo- 
nized with S. aureus ,  7 of 13 (54%) later had devel- 
opment of infection by the same phenotypic 
strains as had been identified in the prior culture 
survey. Patients colonized with MRSA were no 
more likely to have development of subsequent 
infection than patients with MSSA strains (3/7 vs 
4/6; p > 0.05). Two patients with persistent 
stool/rectal colonization later became infected as 
compared with four patients with persistent nasal 
colonization. One patient had both nares and 
stool colonization. 
DISCUSSION 
Few studies of colonization with MRSA have 
been conducted in private, community SNFs. In 
1986 in eight rural Wisconsin nursing homes, 
Sheckler and Peterson 11 found no MRSA coloniza- 
tion. Thomas et al. 4 surveyed a private SNF in Los 
Angeles on two occasions at a 3-month interval 
and found MRSA colonization frequencies of 6.6% 
and 9.1%. In 1991 in a community nursing home 
in Chicago surveyed over 15 months, Hsu 12 found 
that an average of 24% of the patients carried S. 
aureus  and 35% of the isolates were MRSA (8.7% 
of all patients). In 1991 in a VA LTCF study, Muder 
et al.7 reported that 31% and 13% of the patients 
carried S. aureus  and MRSA in their nares. 
Our study in a community SNF in Orange 
County, Calif., has been carried out over more 
than 3 years. In the 1993 to 1994 study of contin- 
uing patients in SNF, we found that an average of 
35% of the patients carried S. aureus ,  and 25% of 
these were MRSA; that is, over the entire period, 
9.7% of al l  patients were colonized with MRSA. 
Most (94%) of the MRSA isolates were also resis- 
tant to ciprofloxacin. The colonization frequency 
of all S. aureus  including MRSA increased gradu- 
ally over this last 1-year surveillance period. The 
prevalence of MRCR strains was higher than the 
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Table 8, Prior colonization and subsequent infection with MR and MS S. aureus, by site of infection 
Phenotypes (no. of patients) 
Site of infection and prior 
colonization MRCR MSCR Not known Total (%) 
Urinary tract 5 0 2 7 (21) 
Positive pcc/Total pcc done 1/3 - ND 
Respiratory 2 6 0 8 (25) 
Positive pcc/Total pcc done 1/1 3/4 - 
Wound/Soft issue 4 5 1 10 (310 
Positive pcc/Total pcc done 1/3 1/2" ND 
Other? 3 4 0 7 (21) 
Positive pcc/Total pcc done ND ND - 
Total infections (%) 14 (44) 15 (47) 3 (9) 32 (100) 
Total positive pcc/Total pcc done 3/7 4/6 - 7/13 
pcc, Prior colonization culture result; ND, no prior colonization culture done. 
*Eyes and wound. 
?Other sites included three eyes, two vaginal, one gastrointestinal, and one multiple sites. 
prevalence 2 years previously, even though the 
percentage of ciprofloxacin prescriptions declined 
slightly. The MRSA nares colonization frequency 
in our study (8.8%) was comparable to that 
reported by Thomas et al. 4 and Hsu 12 in private 
LTCFs, but it was lower than the frequency found 
in a VA LTCF by Muder et al. 7 Thus MR coloniza- 
tion frequencies may vary at different imes and 
in different facilities. 
It is pertinent o address the epidemiologic vir- 
ulence of MRSA compared with MS strains. 
Collopy et al.13 found that MRSA strains were 
more likely than MSSA to be colonizing patients 
in the private SNF they studied. On the other 
hand, in our study of continuing patients in SNF, 
MRSA accounted for a significantly lower propor- 
tion of S. aureus  colonization than MSSA (25% vs 
72%, p < 0.05). Differences in facilities, patient 
populations, and antibiotic utilization patterns 
may explain the differing results, although no 
data are available (clinical, epidemiologic, antibi- 
otic usage, or experimental ssays) to permit spe- 
cific evaluation of potential differences in the vir- 
ulence of antibiotic-resistant phenotype strains. 
However, the findings suggest hat it may be rea- 
sonable for infection control purposes to monitor 
colonization with S. aureus ,  especially MR strains, 
at periodic intervals to detect increasing preva- 
lence and permit possible intervention such as 
increasing emphasis on infection control defen- 
sive measures. 
Little has been reported about the persistence 
of MRSA colonization in patients in community 
SNF and the optimal site for obtaining screening 
cultures to detect MRSA and to follow coloniza- 
tion. In the ACH setting Walsh et al. 14 reported 
that the most useful sites for detecting MRSA col- 
onization were wounds, tracheostomy sites, and 
sputum from intubated patients. Some authors 
have suggested that the anterior nares may be the 
most common site of colonization 15 and yet may 
be a less important reservoir of colonization over 
longer time periods because nasal colonization 
can be transient. On the other hand, Rimland and 
Roberson 16 suggested that, in their VA Medical 
Center, rectal colonization was of equal or per- 
haps greater importance as a reservoir for MRSA 
because it may be more difficult to eradicate from 
this site. Many studies, however, did not include 
both nares and stool specimens in colonization 
screening and therefore may have underestimated 
the true colonization frequency. 1,4,7,17 Our study 
did not include wound specimens; therefore our 
figures could also have underestimated the true 
frequencies. However, the proportion of patients 
in our SNF with wounds was small, and any 
potential underestimate would have been small. 
Our study was designed to include assessment of
the relative value of nares as compared with rectal 
culture sites both for prevalence screening and for 
assessing the persistence of colonization. We 
found that nares specimens detected significantly 
higher S. aureus  colonization frequency than stool 
swabs. However, use of nares alone, without stool 
specimens, would have missed 13% of S. aureus  
colonizations, and half of those missed were resis- 
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tant strains. We also found that in either nares or 
stool swabs, colonization could be either transient 
or persistent. The duration of colonization for 
MRSA in the nares was generally longer than in the 
rectal specimens. Nevertheless, a high percentage 
of patients in SNF are incontinent of stool; persis- 
tent colonization in rectal specimens may contam- 
inate the environment and the hands of personnel 
and may readily serve as a reservoir for dissemina- 
tion of S. aureus ,  including MR strains. 
In our study, a significantly higher proportion 
of continuing patients than newly admitted 
patients were colonized by S. aureus .  This implies 
acquisition of S. aureus  during the nursing home 
stay, because 21% of newly admitted patients who 
were not colonized on admission acquired colo- 
nization after being admitted to the facility. Of 
these about half acquired colonization within 1 
month after admission, and the average length of 
stay for acquisition of S. aureus  colonization was 
47 days. The distribution of antimicrobial pattern 
phenotypes in newly admitted patients was simi- 
lar  to those in continuing patients. The average 
stay in this SNF was 3 months, which is long 
enough to acquire colonization by strains in the 
facility. In a VA LTCF Bradley et al.6 reported that 
10% of the new admission acquired colonization 
while in the facility. 
In our study the majority of the patients were 
admitted from ACH. Our data showed that colo- 
nized patients were no more likely to be admitted 
from ACH than were noncolonized patients. 
However, colonized patients were significantly 
more likely to be admitted from other LTCFs than 
were noncolonized patients. 
It is pertinent o note that in some patients with 
persistent or intermittent colonization, the resis- 
tance phenotype was different at different imes. 
Whether these changes reflected loss or gain of 
resistance factors by the same strain or simply 
acquisition of another strain, and whether the 
MSSA phenotypes, when evaluated by specific 
genotyping, were truly more likely to persist as 
compared with the MRSA phenotype, requires 
further investigation by use of molecular typing. 
Of interest was the finding that one third of the 
colonized patients had negative culture results by 
the end of the study, most with no relation to 
antibiotic therapy. 
With regard to infections caused by S. aureus  in 
our SNF study, 8.8% of all patients had develop- 
ment of S. aureus  infections, and of these 53% 
were due to MRSA. In VA LTCF studies, Spindel 
et al. 18 and Muder et al. 7 found annual total S. 
aureus  infection rates of approximately 4.3% and 
7.6% respectively, of which about 41% and 75% 
were due to MRSA. Thus the analogous S. aureus  
infection frequency in our SNF was slightly high- 
er than in these VA LTCF  studies. 
Some investigators have suggested that MRSA 
strains may be less virulent than MSSA, 13 whereas 
others have indicated that MRSA are more viru- 
lent. 7 In our study we could not demonstrate any 
differences in the ability of sensitive or resistant 
strains to cause infection. However, our numbers 
were too small for critical analysis. Furthermore, 
no one was hospitalized or died of MRSA infec- 
tion during the study period. Muder et al.7 sug- 
gested that underlying host factors are likely to be 
the most important factors leading to progression 
from colonization to infection. Similarly, in our 
study colonized patients who subsequently had 
development of infection were significantly more 
debilitated. Of patients with S. aureus  infections, 
seven of 13 (53%) had been colonized previously 
with the same phenotype that later caused infec- 
tion. Thus persistent colonization in debilitated 
patients is both a predictor and a risk factor for 
development of infection with S. aureus  in the 
SNF setting; potential prevention and control 
measures hould focus on the more debilitated 
patients. The low-to-moderate l vel of coloniza- 
tion and infection found in our study certainly 
does not constitute an epidemic situation in this 
SNE However, the gradual increase in coloniza- 
tion and in infection frequencies over the past 3 
years is of concern and suggests that in this SNF, 
specific intervention strategies could become war- 
ranted in the future. 
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